speb/financial-data huggingface dataset:
CELH income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 107999000.00
CELH income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 24739000.00
CELH income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 107999000.00
CELH income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 24739000.00
CELH cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 107999000.00
CELH cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 24739000.00
CELH income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 107999000.00
CELH income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 24739000.00
CELH income_statement (annual, 2025-12-31) — Net Interest Income: -27892000.00
CELH income_statement (quarterly, 2025-12-31) — Net Interest Income: -8300000.00
CELH cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -10000000.00
CELH cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -5000000.00
CELH cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 698250000.00
CELH cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -199500000.00
CELH cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 698250000.00
CELH cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -199500000.00
CELH income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -27892000.00
CELH income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -8300000.00
CELH cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -32374000.00
CELH cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -1094000.00
CELH cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 29156000.00
CELH cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -1461000.00
CELH balance_sheet (annual, 2025-12-31) — Net PPE: 87910000.00
CELH balance_sheet (quarterly, 2025-12-31) — Net PPE: 87910000.00
CELH cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -36067000.00
CELH cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -10528000.00
CELH balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 631967000.00
CELH balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 631967000.00
CELH balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 867648000.00
CELH balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 867648000.00
CELH balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 401155000.00
CELH balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 401155000.00
CELH balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 401155000.00
CELH balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 401155000.00
CELH balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 96013000.00
CELH balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 96013000.00
CELH income_statement (annual, 2025-12-31) — Normalized EBITDA: 530922000.00
CELH income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 124949000.00
CELH income_statement (annual, 2025-12-31) — Normalized Income: 390925304.00
CELH income_statement (quarterly, 2025-12-31) — Normalized Income: 88534660.00
CELH cash_flow (annual, 2025-12-31) — Operating Cash Flow: 359442000.00
CELH cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -119438000.00
CELH cash_flow (annual, 2025-12-31) — Operating Gains Losses: 6003000.00
CELH income_statement (annual, 2025-12-31) — Operating Income: 468523000.00
CELH income_statement (quarterly, 2025-12-31) — Operating Income: 106819000.00
CELH income_statement (annual, 2025-12-31) — Operating Revenue: 2515269000.00
CELH income_statement (quarterly, 2025-12-31) — Operating Revenue: 721628000.00
CELH balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 256906000.00
CELH balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 256906000.00
CELH balance_sheet (annual, 2025-12-31) — Other Current Assets: 128806000.00
CELH balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 128806000.00
CELH balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 61465000.00
CELH balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 61465000.00
CELH balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 3162000.00
CELH balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 3162000.00
CELH income_statement (annual, 2025-12-31) — Other Income Expense: -315598000.00
CELH income_statement (quarterly, 2025-12-31) — Other Income Expense: -75913000.00
CELH balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 1391915000.00
CELH balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 1391915000.00
CELH cash_flow (annual, 2025-12-31) — Other Non Cash Items: 38439000.00
CELH cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 9284000.00
CELH balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 43434000.00
CELH balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 43434000.00
CELH balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 28372000.00
CELH balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 28372000.00
CELH income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 11863000.00
CELH income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 4841000.00
CELH balance_sheet (annual, 2025-12-31) — Other Properties: 60615000.00
CELH balance_sheet (quarterly, 2025-12-31) — Other Properties: 60615000.00
CELH income_statement (annual, 2025-12-31) — Other Special Charges: 327461000.00
CELH income_statement (quarterly, 2025-12-31) — Other Special Charges: 80754000.00
CELH income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 6554000.00
CELH income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 1282000.00
CELH balance_sheet (annual, 2025-12-31) — Payables: 187542000.00
CELH balance_sheet (quarterly, 2025-12-31) — Payables: 187542000.00
CELH balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 990273000.00
CELH balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 990273000.00
CELH balance_sheet (annual, 2025-12-31) — Preferred Stock: 1759975000.00
CELH balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 1759975000.00
CELH cash_flow (annual, 2025-12-31) — Preferred Stock Dividend Paid: -37608000.00
CELH cash_flow (quarterly, 2025-12-31) — Preferred Stock Dividend Paid: -14307000.00
CELH income_statement (annual, 2025-12-31) — Preferred Stock Dividends: 37608000.00
CELH income_statement (quarterly, 2025-12-31) — Preferred Stock Dividends: 14319000.00
CELH balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 1759975000.00
CELH balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 1759975000.00
CELH income_statement (annual, 2025-12-31) — Pretax Income: 125033000.00
CELH income_statement (quarterly, 2025-12-31) — Pretax Income: 22606000.00
CELH balance_sheet (annual, 2025-12-31) — Properties: 0.00
CELH balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CELH cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 39790000.00
CELH cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 14251000.00
CELH cash_flow (annual, 2025-12-31) — Purchase Of Business: -1278769000.00
CELH cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
CELH cash_flow (annual, 2025-12-31) — Purchase Of Investment: -10000000.00
CELH cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -5000000.00
CELH cash_flow (annual, 2025-12-31) — Purchase Of PPE: -36067000.00
CELH cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -10528000.00
CELH balance_sheet (annual, 2025-12-31) — Raw Materials: 74654000.00
CELH balance_sheet (quarterly, 2025-12-31) — Raw Materials: 74654000.00
CELH balance_sheet (annual, 2025-12-31) — Receivables: 755499000.00
CELH balance_sheet (quarterly, 2025-12-31) — Receivables: 755499000.00
CELH income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 1247936000.00
CELH income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 379798000.00
CELH income_statement (annual, 2025-12-31) — Reconciled Depreciation: 29451000.00
CELH income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 8935000.00
CELH cash_flow (annual, 2025-12-31) — Repayment Of Debt: -201750000.00
CELH cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -199500000.00
CELH cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -45504000.00
CELH cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -42245000.00
CELH balance_sheet (annual, 2025-12-31) — Restricted Cash: 141121000.00
CELH balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 141121000.00
CELH balance_sheet (annual, 2025-12-31) — Retained Earnings: 175912000.00
CELH balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 175912000.00
CELH income_statement (annual, 2025-12-31) — Selling General And Administration: 798810000.00
CELH income_statement (quarterly, 2025-12-31) — Selling General And Administration: 235011000.00
CELH balance_sheet (annual, 2025-12-31) — Share Issued: 258108000.00
CELH balance_sheet (quarterly, 2025-12-31) — Share Issued: 258108000.00
CELH income_statement (annual, 2025-12-31) — Special Income Charges: -327461000.00
CELH income_statement (quarterly, 2025-12-31) — Special Income Charges: -80754000.00
CELH cash_flow (annual, 2025-12-31) — Stock Based Compensation: 28050000.00
CELH cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 9203000.00
CELH balance_sheet (annual, 2025-12-31) — Stockholders Equity: 2941442000.00
CELH balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 2941442000.00
CELH balance_sheet (annual, 2025-12-31) — Tangible Book Value: -1128008000.00
CELH balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -1128008000.00
CELH income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -44534696.00
CELH income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -16958340.00
CELH income_statement (annual, 2025-12-31) — Tax Provision: 17034000.00
CELH income_statement (quarterly, 2025-12-31) — Tax Provision: -2133000.00
CELH income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.14
CELH income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
CELH balance_sheet (annual, 2025-12-31) — Total Assets: 5119621000.00
CELH balance_sheet (quarterly, 2025-12-31) — Total Assets: 5119621000.00
CELH balance_sheet (annual, 2025-12-31) — Total Capitalization: 3611368000.00
CELH balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 3611368000.00
CELH balance_sheet (annual, 2025-12-31) — Total Debt: 669926000.00
CELH balance_sheet (quarterly, 2025-12-31) — Total Debt: 669926000.00
CELH balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 2941442000.00
CELH balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 2941442000.00
CELH income_statement (annual, 2025-12-31) — Total Expenses: 2046746000.00
CELH income_statement (quarterly, 2025-12-31) — Total Expenses: 614809000.00
CELH balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 2178179000.00
CELH balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 2178179000.00
CELH balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 3308467000.00
CELH balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 3308467000.00
CELH balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1099453000.00
CELH balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1099453000.00
CELH income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 141062000.00
CELH income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 26065000.00
CELH balance_sheet (annual, 2025-12-31) — Total Tax Payable: 49612000.00
CELH balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 49612000.00
CELH income_statement (annual, 2025-12-31) — Total Unusual Items: -327461000.00
CELH income_statement (quarterly, 2025-12-31) — Total Unusual Items: -80754000.00
CELH income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -327461000.00
CELH income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -80754000.00
CELH balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 1202000.00
CELH balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 1202000.00
CELH balance_sheet (annual, 2025-12-31) — Treasury Stock: 48226000.00
CELH balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 48226000.00
CELH balance_sheet (annual, 2025-12-31) — Working Capital: 732428000.00
CELH balance_sheet (quarterly, 2025-12-31) — Working Capital: 732428000.00
CELH income_statement (quarterly, 2026-03-31) — +Operating Expense: 234647000.00
CELH income_statement (quarterly, 2026-03-31) — +Total Revenue: 782615000.00
CELH balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 198225000.00
CELH balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 832373000.00
CELH balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 1058144000.00
CELH income_statement (quarterly, 2026-03-31) — Average Dilution Earnings: 104000.00
CELH income_statement (quarterly, 2026-03-31) — Basic Average Shares: 257818182.00
CELH income_statement (quarterly, 2026-03-31) — Basic EPS: 0.33
CELH cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 539987000.00
CELH cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -7916000.00
CELH balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1760076000.00
CELH balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 549201000.00
CELH balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 549201000.00
CELH cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -13992000.00
CELH cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -55858000.00
CELH cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -7675000.00
CELH cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 73723000.00
CELH cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 58049000.00
CELH cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -185148000.00
CELH cash_flow (quarterly, 2026-03-31) — Change In Income Tax Payable: 14835000.00
CELH cash_flow (quarterly, 2026-03-31) — Change In Inventory: -28197000.00
CELH cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 1123000.00
CELH cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 6029000.00
CELH cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 87166000.00
CELH cash_flow (quarterly, 2026-03-31) — Change In Payable: 72884000.00
CELH cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -112264000.00
CELH cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 59538000.00
CELH cash_flow (quarterly, 2026-03-31) — Change In Receivables: -79978000.00
CELH cash_flow (quarterly, 2026-03-31) — Change In Tax Payable: 14835000.00
CELH cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -66583000.00
CELH cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -79978000.00
CELH cash_flow (quarterly, 2026-03-31) — Changes In Cash: 10190000.00
CELH balance_sheet (quarterly, 2026-03-31) — Common Stock: 101000.00
CELH balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1250762000.00
CELH cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -28891000.00
CELH income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 404548000.00
CELH balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 719087000.00
CELH balance_sheet (quarterly, 2026-03-31) — Current Assets: 1864278000.00
CELH balance_sheet (quarterly, 2026-03-31) — Current Deferred Assets: 49472000.00
CELH balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 26869000.00
CELH balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 26869000.00
CELH balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1051333000.00
CELH cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 9515000.00
CELH cash_flow (quarterly, 2026-03-31) — Deferred Tax: 9515000.00
CELH cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 9134000.00
CELH cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 9134000.00
CELH income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 257818182.00
CELH income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.33
CELH income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 85184000.00
CELH income_statement (quarterly, 2026-03-31) — EBIT: 149379000.00
CELH income_statement (quarterly, 2026-03-31) — EBITDA: 158513000.00
CELH cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -976000.00
CELH cash_flow (quarterly, 2026-03-31) — End Cash Position: 549201000.00
CELH cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -55858000.00
CELH balance_sheet (quarterly, 2026-03-31) — Finished Goods: 266990000.00
CELH cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 65807000.00
CELH balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 1619000.00
CELH balance_sheet (quarterly, 2026-03-31) — Goodwill: 919793000.00
CELH balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 2305551000.00
CELH balance_sheet (quarterly, 2026-03-31) — Gross PPE: 96783000.00
CELH income_statement (quarterly, 2026-03-31) — Gross Profit: 378067000.00
CELH cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 535000.00
CELH balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 64447000.00
CELH income_statement (quarterly, 2026-03-31) — Interest Expense: 11843000.00
CELH income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 11843000.00
CELH income_statement (quarterly, 2026-03-31) — Interest Income: 2992000.00
CELH income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 2992000.00
CELH cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 10899000.00
CELH balance_sheet (quarterly, 2026-03-31) — Inventories Adjustments Allowances: -9805000.00
CELH balance_sheet (quarterly, 2026-03-31) — Inventory: 364146000.00
CELH balance_sheet (quarterly, 2026-03-31) — Invested Capital: 1919643000.00
CELH cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -7675000.00
CELH balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 668881000.00
CELH balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 668881000.00
CELH cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -1750000.00
CELH cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -28891000.00
CELH balance_sheet (quarterly, 2026-03-31) — Net Debt: 119680000.00
CELH income_statement (quarterly, 2026-03-31) — Net Income: 110099000.00
CELH income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 85080000.00
CELH income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 110099000.00
CELH income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 110099000.00
CELH income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 110099000.00
CELH cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 110099000.00
CELH income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 110099000.00
CELH income_statement (quarterly, 2026-03-31) — Net Interest Income: -8851000.00
CELH cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -1750000.00
CELH cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -1750000.00
CELH income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -8851000.00
CELH cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -11225000.00
CELH cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 241000.00
CELH balance_sheet (quarterly, 2026-03-31) — Net PPE: 96783000.00
CELH cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -7916000.00
CELH balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 705186000.00
CELH balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 845529000.00
CELH balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 395279000.00
CELH balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 395279000.00
CELH balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 86448000.00
CELH income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 162940000.00
CELH income_statement (quarterly, 2026-03-31) — Normalized Income: 113645027.00
CELH cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 73723000.00
CELH income_statement (quarterly, 2026-03-31) — Operating Income: 143420000.00
CELH income_statement (quarterly, 2026-03-31) — Operating Revenue: 782615000.00
CELH balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 256549000.00
CELH balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 69086000.00
CELH balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 42705000.00
CELH balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 1619000.00
CELH income_statement (quarterly, 2026-03-31) — Other Income Expense: 2967000.00
CELH balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 1385758000.00
CELH cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -866000.00
CELH balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 45452000.00
CELH balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 31363000.00
CELH income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 7394000.00
CELH balance_sheet (quarterly, 2026-03-31) — Other Properties: 96783000.00
CELH income_statement (quarterly, 2026-03-31) — Other Special Charges: 4427000.00
CELH income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 11026000.00
CELH balance_sheet (quarterly, 2026-03-31) — Payables: 262672000.00
CELH balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 981759000.00
CELH balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 1759975000.00
CELH cash_flow (quarterly, 2026-03-31) — Preferred Stock Dividend Paid: -13992000.00
CELH income_statement (quarterly, 2026-03-31) — Preferred Stock Dividends: 13993000.00
CELH balance_sheet (quarterly, 2026-03-31) — Preferred Stock Equity: 1759975000.00
CELH income_statement (quarterly, 2026-03-31) — Pretax Income: 137536000.00
CELH cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 4798000.00
CELH cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -7916000.00
CELH balance_sheet (quarterly, 2026-03-31) — Raw Materials: 106961000.00
CELH balance_sheet (quarterly, 2026-03-31) — Receivables: 832373000.00
CELH income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 404548000.00
CELH income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 9134000.00
CELH cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -1750000.00
CELH cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -28891000.00
CELH balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 0.00
CELH balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 272019000.00
CELH income_statement (quarterly, 2026-03-31) — Selling General And Administration: 234647000.00
CELH balance_sheet (quarterly, 2026-03-31) — Share Issued: 258601000.00
CELH income_statement (quarterly, 2026-03-31) — Special Income Charges: -4427000.00
CELH cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 7626000.00
CELH balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 3010737000.00
CELH balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -1054789000.00
CELH income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -880973.00
CELH income_statement (quarterly, 2026-03-31) — Tax Provision: 27437000.00
CELH income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.20
CELH balance_sheet (quarterly, 2026-03-31) — Total Assets: 5157593000.00
CELH balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 3679618000.00
CELH balance_sheet (quarterly, 2026-03-31) — Total Debt: 668881000.00
CELH balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 3010737000.00
CELH income_statement (quarterly, 2026-03-31) — Total Expenses: 639195000.00
CELH balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 2146856000.00
CELH balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 3293315000.00
CELH balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1095523000.00
CELH income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 138993000.00
CELH balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 64447000.00
CELH income_statement (quarterly, 2026-03-31) — Total Unusual Items: -4427000.00
CELH income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -4427000.00
CELH balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 2052000.00
CELH balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 81121000.00
CELH balance_sheet (quarterly, 2026-03-31) — Working Capital: 812945000.00
CELL.V cash_flow (annual, 2021-06-30) — Capital Expenditure: -479538.00
CELL.V balance_sheet (annual, 2021-06-30) — Current Debt And Capital Lease Obligation: 21859.00
CELL.V income_statement (annual, 2021-06-30) — Gain On Sale Of Ppe: 0.00
CELL.V income_statement (annual, 2021-06-30) — Interest Expense: 2054.00
CELL.V income_statement (annual, 2021-06-30) — Interest Expense Non Operating: 2054.00
CELL.V income_statement (annual, 2021-06-30) — Interest Income: 0.00
CELL.V income_statement (annual, 2021-06-30) — Interest Income Non Operating: 0.00
CELL.V balance_sheet (annual, 2021-06-30) — Long Term Debt And Capital Lease Obligation: 0.00
CELL.V cash_flow (annual, 2021-06-30) — Net PPE Purchase And Sale: -479538.00
CELL.V cash_flow (annual, 2021-06-30) — Other Non Cash Items: 1371.00
CELL.V balance_sheet (annual, 2021-06-30) — Other Non Current Assets: 35000.00
CELL.V balance_sheet (annual, 2021-06-30) — Other Receivables: 13336.00
CELL.V balance_sheet (annual, 2021-06-30) — Other Short Term Investments: 0.00
CELL.V cash_flow (annual, 2021-06-30) — Purchase Of PPE: -479538.00
CELL.V income_statement (annual, 2021-06-30) — Rent And Landing Fees: 32190.00
CELL.V income_statement (annual, 2021-06-30) — Rent Expense Supplemental: 32190.00
CELL.V income_statement (annual, 2021-06-30) — Salaries And Wages: 252080.00
CELL.V cash_flow (annual, 2021-06-30) — Stock Based Compensation: 252080.00
CELL.V income_statement (annual, 2022-06-30) — +Operating Expense: 358237.00
CELL.V income_statement (annual, 2022-06-30) — +Total Revenue: 0.00
CELL.V balance_sheet (annual, 2022-06-30) — Accounts Payable: 1483.00
CELL.V cash_flow (annual, 2022-06-30) — Asset Impairment Charge: 1812415.00
CELL.V income_statement (annual, 2022-06-30) — Basic Average Shares: 71342578.00
CELL.V income_statement (annual, 2022-06-30) — Basic EPS: -0.04
CELL.V cash_flow (annual, 2022-06-30) — Beginning Cash Position: 1301655.00
CELL.V cash_flow (annual, 2022-06-30) — Capital Expenditure: -536541.00
CELL.V balance_sheet (annual, 2022-06-30) — Capital Lease Obligations: 0.00
CELL.V balance_sheet (annual, 2022-06-30) — Capital Stock: 9111572.00
CELL.V balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 502109.00
CELL.V balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 752109.00
CELL.V balance_sheet (annual, 2022-06-30) — Cash Financial: 502109.00
CELL.V cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Financing Activities: 131391.00
CELL.V cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Investing Activities: -536541.00
CELL.V cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Operating Activities: -394396.00
CELL.V cash_flow (annual, 2022-06-30) — Change In Payable: -12537.00
CELL.V cash_flow (annual, 2022-06-30) — Change In Payables And Accrued Expense: -12537.00
CELL.V cash_flow (annual, 2022-06-30) — Change In Prepaid Assets: -19546.00
CELL.V cash_flow (annual, 2022-06-30) — Change In Receivables: 502.00
CELL.V cash_flow (annual, 2022-06-30) — Change In Working Capital: -31581.00
CELL.V cash_flow (annual, 2022-06-30) — Changes In Cash: -799546.00
CELL.V balance_sheet (annual, 2022-06-30) — Common Stock: 9111572.00
CELL.V balance_sheet (annual, 2022-06-30) — Common Stock Equity: 1669586.00
CELL.V cash_flow (annual, 2022-06-30) — Common Stock Issuance: 0.00
CELL.V income_statement (annual, 2022-06-30) — Cost Of Revenue: 21017.00
CELL.V balance_sheet (annual, 2022-06-30) — Current Accrued Expenses: 20000.00
CELL.V balance_sheet (annual, 2022-06-30) — Current Assets: 820248.00
CELL.V balance_sheet (annual, 2022-06-30) — Current Capital Lease Obligation: 0.00
CELL.V balance_sheet (annual, 2022-06-30) — Current Liabilities: 21483.00
CELL.V cash_flow (annual, 2022-06-30) — Depreciation: 21017.00
CELL.V cash_flow (annual, 2022-06-30) — Depreciation Amortization Depletion: 21017.00
CELL.V cash_flow (annual, 2022-06-30) — Depreciation And Amortization: 21017.00
CELL.V income_statement (annual, 2022-06-30) — Diluted Average Shares: 71342578.00
CELL.V income_statement (annual, 2022-06-30) — Diluted EPS: -0.04
CELL.V income_statement (annual, 2022-06-30) — Diluted NI Availto Com Stockholders: -3021247.00
CELL.V income_statement (annual, 2022-06-30) — EBIT: -379254.00
CELL.V income_statement (annual, 2022-06-30) — EBITDA: -358237.00
CELL.V cash_flow (annual, 2022-06-30) — End Cash Position: 502109.00
CELL.V cash_flow (annual, 2022-06-30) — Financing Cash Flow: 131391.00
CELL.V cash_flow (annual, 2022-06-30) — Free Cash Flow: -394396.00
CELL.V cash_flow (annual, 2022-06-30) — Gain Loss On Sale Of PPE: 0.00
CELL.V income_statement (annual, 2022-06-30) — Gain On Sale Of Ppe: -500.00
CELL.V income_statement (annual, 2022-06-30) — Gain On Sale Of Security: -828099.00
CELL.V balance_sheet (annual, 2022-06-30) — Gains Losses Not Affecting Retained Earnings: 4566124.00
CELL.V income_statement (annual, 2022-06-30) — General And Administrative Expense: 345744.00
CELL.V balance_sheet (annual, 2022-06-30) — Gross PPE: 835821.00
CELL.V income_statement (annual, 2022-06-30) — Gross Profit: -21017.00
CELL.V income_statement (annual, 2022-06-30) — Impairment Of Capital Assets: 1812415.00
CELL.V income_statement (annual, 2022-06-30) — Insurance And Claims: 19265.00
CELL.V income_statement (annual, 2022-06-30) — Interest Expense: 979.00
CELL.V income_statement (annual, 2022-06-30) — Interest Expense Non Operating: 979.00
CELL.V balance_sheet (annual, 2022-06-30) — Invested Capital: 1669586.00
CELL.V cash_flow (annual, 2022-06-30) — Investing Cash Flow: -536541.00
CELL.V cash_flow (annual, 2022-06-30) — Issuance Of Capital Stock: 0.00
CELL.V balance_sheet (annual, 2022-06-30) — Long Term Capital Lease Obligation: 0.00
CELL.V cash_flow (annual, 2022-06-30) — Long Term Debt Payments: -21859.00
CELL.V cash_flow (annual, 2022-06-30) — Net Common Stock Issuance: 0.00
CELL.V income_statement (annual, 2022-06-30) — Net Income: -3021247.00
CELL.V income_statement (annual, 2022-06-30) — Net Income Common Stockholders: -3021247.00
CELL.V income_statement (annual, 2022-06-30) — Net Income Continuous Operations: -3021247.00
CELL.V income_statement (annual, 2022-06-30) — Net Income From Continuing And Discontinued Operation: -3021247.00
CELL.V income_statement (annual, 2022-06-30) — Net Income From Continuing Operation Net Minority Interest: -3021247.00
CELL.V cash_flow (annual, 2022-06-30) — Net Income From Continuing Operations: -3021247.00
CELL.V income_statement (annual, 2022-06-30) — Net Income Including Noncontrolling Interests: -3021247.00
CELL.V income_statement (annual, 2022-06-30) — Net Interest Income: -979.00
CELL.V cash_flow (annual, 2022-06-30) — Net Issuance Payments Of Debt: -21859.00
CELL.V cash_flow (annual, 2022-06-30) — Net Long Term Debt Issuance: -21859.00
CELL.V income_statement (annual, 2022-06-30) — Net Non Operating Interest Income Expense: -979.00
CELL.V cash_flow (annual, 2022-06-30) — Net Other Investing Changes: -536541.00
CELL.V balance_sheet (annual, 2022-06-30) — Net PPE: 835821.00
CELL.V cash_flow (annual, 2022-06-30) — Net PPE Purchase And Sale: -536541.00
CELL.V balance_sheet (annual, 2022-06-30) — Net Tangible Assets: 1669586.00
CELL.V income_statement (annual, 2022-06-30) — Normalized EBITDA: 2282777.00
CELL.V income_statement (annual, 2022-06-30) — Normalized Income: -380233.00
CELL.V cash_flow (annual, 2022-06-30) — Operating Cash Flow: -394396.00
CELL.V income_statement (annual, 2022-06-30) — Operating Income: -379254.00
CELL.V income_statement (annual, 2022-06-30) — Operating Revenue: 0.00
CELL.V balance_sheet (annual, 2022-06-30) — Ordinary Shares Number: 72309153.00
CELL.V income_statement (annual, 2022-06-30) — Other Gand A: 286060.00
CELL.V income_statement (annual, 2022-06-30) — Other Income Expense: -2641014.00
CELL.V balance_sheet (annual, 2022-06-30) — Other Non Current Assets: 35000.00
CELL.V income_statement (annual, 2022-06-30) — Other Operating Expenses: 27936.00
CELL.V balance_sheet (annual, 2022-06-30) — Other Properties: 835821.00
CELL.V balance_sheet (annual, 2022-06-30) — Other Receivables: 13336.00
CELL.V balance_sheet (annual, 2022-06-30) — Other Short Term Investments: 250000.00
CELL.V balance_sheet (annual, 2022-06-30) — Payables: 1483.00
CELL.V balance_sheet (annual, 2022-06-30) — Payables And Accrued Expenses: 21483.00
CELL.V balance_sheet (annual, 2022-06-30) — Prepaid Assets: 22947.00
CELL.V income_statement (annual, 2022-06-30) — Pretax Income: -3021247.00
CELL.V cash_flow (annual, 2022-06-30) — Proceeds From Stock Option Exercised: 153250.00
CELL.V cash_flow (annual, 2022-06-30) — Purchase Of PPE: -536541.00
CELL.V balance_sheet (annual, 2022-06-30) — Receivables: 45192.00
CELL.V income_statement (annual, 2022-06-30) — Reconciled Cost Of Revenue: 21017.00
CELL.V income_statement (annual, 2022-06-30) — Reconciled Depreciation: 21017.00
CELL.V income_statement (annual, 2022-06-30) — Rent And Landing Fees: 40419.00
CELL.V income_statement (annual, 2022-06-30) — Rent Expense Supplemental: 40419.00
CELL.V cash_flow (annual, 2022-06-30) — Repayment Of Debt: -21859.00
CELL.V balance_sheet (annual, 2022-06-30) — Retained Earnings: -12008110.00
CELL.V income_statement (annual, 2022-06-30) — Salaries And Wages: 0.00
CELL.V income_statement (annual, 2022-06-30) — Securities Amortization: 0.00
CELL.V income_statement (annual, 2022-06-30) — Selling And Marketing Expense: 12493.00
CELL.V income_statement (annual, 2022-06-30) — Selling General And Administration: 358237.00
CELL.V balance_sheet (annual, 2022-06-30) — Share Issued: 72309153.00
CELL.V income_statement (annual, 2022-06-30) — Special Income Charges: -1812915.00
CELL.V cash_flow (annual, 2022-06-30) — Stock Based Compensation: 0.00
CELL.V balance_sheet (annual, 2022-06-30) — Stockholders Equity: 1669586.00
CELL.V balance_sheet (annual, 2022-06-30) — Tangible Book Value: 1669586.00
CELL.V income_statement (annual, 2022-06-30) — Tax Effect Of Unusual Items: 0.00
CELL.V income_statement (annual, 2022-06-30) — Tax Rate For Calcs: 0.00
CELL.V balance_sheet (annual, 2022-06-30) — Taxes Receivable: 31856.00
CELL.V balance_sheet (annual, 2022-06-30) — Total Assets: 1691069.00
CELL.V balance_sheet (annual, 2022-06-30) — Total Capitalization: 1669586.00
CELL.V balance_sheet (annual, 2022-06-30) — Total Debt: 0.00
CELL.V balance_sheet (annual, 2022-06-30) — Total Equity Gross Minority Interest: 1669586.00
CELL.V income_statement (annual, 2022-06-30) — Total Expenses: 379254.00
CELL.V balance_sheet (annual, 2022-06-30) — Total Liabilities Net Minority Interest: 21483.00
CELL.V balance_sheet (annual, 2022-06-30) — Total Non Current Assets: 870821.00
CELL.V balance_sheet (annual, 2022-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
CELL.V income_statement (annual, 2022-06-30) — Total Other Finance Cost: 979.00
CELL.V income_statement (annual, 2022-06-30) — Total Unusual Items: -2641014.00
CELL.V income_statement (annual, 2022-06-30) — Total Unusual Items Excluding Goodwill: -2641014.00
CELL.V cash_flow (annual, 2022-06-30) — Unrealized Gain Loss On Investment Securities: 825000.00
CELL.V balance_sheet (annual, 2022-06-30) — Working Capital: 798765.00
CELL.V income_statement (annual, 2023-06-30) — +Operating Expense: 1077181.00
CELL.V income_statement (annual, 2023-06-30) — +Total Revenue: 0.00
CELL.V balance_sheet (annual, 2023-06-30) — Accounts Payable: 2659.00
CELL.V cash_flow (annual, 2023-06-30) — Asset Impairment Charge: 374750.00
CELL.V income_statement (annual, 2023-06-30) — Basic Average Shares: 86527959.00
CELL.V income_statement (annual, 2023-06-30) — Basic EPS: 0.01
CELL.V cash_flow (annual, 2023-06-30) — Beginning Cash Position: 502109.00
CELL.V balance_sheet (annual, 2023-06-30) — Capital Lease Obligations: 25465.00
CELL.V balance_sheet (annual, 2023-06-30) — Capital Stock: 13482924.00
CELL.V balance_sheet (annual, 2023-06-30) — Cash And Cash Equivalents: 4246147.00
CELL.V balance_sheet (annual, 2023-06-30) — Cash Cash Equivalents And Short Term Investments: 7246147.00
CELL.V balance_sheet (annual, 2023-06-30) — Cash Financial: 4246147.00
CELL.V cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Financing Activities: 4391464.00
CELL.V cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Investing Activities: -132753.00
CELL.V cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Operating Activities: -514673.00
CELL.V cash_flow (annual, 2023-06-30) — Change In Payable: 8176.00
CELL.V cash_flow (annual, 2023-06-30) — Change In Payables And Accrued Expense: 8176.00
CELL.V cash_flow (annual, 2023-06-30) — Change In Prepaid Assets: -28991.00
CELL.V cash_flow (annual, 2023-06-30) — Change In Receivables: 36604.00
CELL.V cash_flow (annual, 2023-06-30) — Change In Working Capital: 15789.00
CELL.V cash_flow (annual, 2023-06-30) — Changes In Cash: 3744038.00
CELL.V balance_sheet (annual, 2023-06-30) — Common Stock: 13482924.00
CELL.V balance_sheet (annual, 2023-06-30) — Common Stock Equity: 7769543.00
CELL.V cash_flow (annual, 2023-06-30) — Common Stock Issuance: 4399464.00
CELL.V income_statement (annual, 2023-06-30) — Cost Of Revenue: 7090.00
CELL.V balance_sheet (annual, 2023-06-30) — Current Accrued Expenses: 27000.00
CELL.V balance_sheet (annual, 2023-06-30) — Current Assets: 7306673.00
CELL.V balance_sheet (annual, 2023-06-30) — Current Capital Lease Obligation: 10336.00
CELL.V balance_sheet (annual, 2023-06-30) — Current Debt And Capital Lease Obligation: 10336.00
CELL.V balance_sheet (annual, 2023-06-30) — Current Liabilities: 39995.00
CELL.V cash_flow (annual, 2023-06-30) — Depreciation: 7090.00
CELL.V cash_flow (annual, 2023-06-30) — Depreciation Amortization Depletion: 7090.00
CELL.V cash_flow (annual, 2023-06-30) — Depreciation And Amortization: 7090.00
CELL.V income_statement (annual, 2023-06-30) — Diluted Average Shares: 95288906.00
CELL.V income_statement (annual, 2023-06-30) — Diluted EPS: 0.01
CELL.V income_statement (annual, 2023-06-30) — Diluted NI Availto Com Stockholders: 1168850.00
CELL.V income_statement (annual, 2023-06-30) — EBIT: -1084271.00
CELL.V income_statement (annual, 2023-06-30) — EBITDA: -1077181.00
CELL.V cash_flow (annual, 2023-06-30) — End Cash Position: 4246147.00
CELL.V cash_flow (annual, 2023-06-30) — Financing Cash Flow: 4391464.00
CELL.V cash_flow (annual, 2023-06-30) — Free Cash Flow: -514673.00
CELL.V cash_flow (annual, 2023-06-30) — Gain Loss On Sale Of PPE: -84353.00
CELL.V income_statement (annual, 2023-06-30) — Gain On Sale Of Ppe: 84353.00
CELL.V income_statement (annual, 2023-06-30) — Gain On Sale Of Security: 2545071.00
CELL.V balance_sheet (annual, 2023-06-30) — Gains Losses Not Affecting Retained Earnings: 5125879.00
CELL.V income_statement (annual, 2023-06-30) — General And Administrative Expense: 1056873.00
CELL.V balance_sheet (annual, 2023-06-30) — Gross PPE: 482994.00
CELL.V income_statement (annual, 2023-06-30) — Gross Profit: -7090.00
CELL.V income_statement (annual, 2023-06-30) — Impairment Of Capital Assets: 374750.00
CELL.V income_statement (annual, 2023-06-30) — Insurance And Claims: 20015.00
CELL.V income_statement (annual, 2023-06-30) — Interest Income: 0.00
CELL.V income_statement (annual, 2023-06-30) — Interest Income Non Operating: 0.00
CELL.V balance_sheet (annual, 2023-06-30) — Invested Capital: 7769543.00
CELL.V cash_flow (annual, 2023-06-30) — Investing Cash Flow: -132753.00
CELL.V cash_flow (annual, 2023-06-30) — Issuance Of Capital Stock: 4399464.00
CELL.V balance_sheet (annual, 2023-06-30) — Long Term Capital Lease Obligation: 15129.00
CELL.V balance_sheet (annual, 2023-06-30) — Long Term Debt And Capital Lease Obligation: 15129.00
CELL.V cash_flow (annual, 2023-06-30) — Long Term Debt Payments: -8000.00
CELL.V cash_flow (annual, 2023-06-30) — Net Common Stock Issuance: 4399464.00
CELL.V income_statement (annual, 2023-06-30) — Net Income: 1168850.00
CELL.V income_statement (annual, 2023-06-30) — Net Income Common Stockholders: 1168850.00
CELL.V income_statement (annual, 2023-06-30) — Net Income Continuous Operations: 1168850.00
CELL.V income_statement (annual, 2023-06-30) — Net Income From Continuing And Discontinued Operation: 1168850.00
CELL.V income_statement (annual, 2023-06-30) — Net Income From Continuing Operation Net Minority Interest: 1168850.00
CELL.V cash_flow (annual, 2023-06-30) — Net Income From Continuing Operations: 1168850.00
CELL.V income_statement (annual, 2023-06-30) — Net Income Including Noncontrolling Interests: 1168850.00
CELL.V income_statement (annual, 2023-06-30) — Net Interest Income: -1553.00
CELL.V cash_flow (annual, 2023-06-30) — Net Investment Purchase And Sale: 0.00
CELL.V cash_flow (annual, 2023-06-30) — Net Issuance Payments Of Debt: -8000.00
CELL.V cash_flow (annual, 2023-06-30) — Net Long Term Debt Issuance: -8000.00
CELL.V income_statement (annual, 2023-06-30) — Net Non Operating Interest Income Expense: -1553.00
CELL.V cash_flow (annual, 2023-06-30) — Net Other Investing Changes: -132753.00
CELL.V balance_sheet (annual, 2023-06-30) — Net PPE: 482994.00
CELL.V balance_sheet (annual, 2023-06-30) — Net Tangible Assets: 7769543.00
CELL.V income_statement (annual, 2023-06-30) — Normalized EBITDA: -3331855.00
CELL.V income_statement (annual, 2023-06-30) — Normalized Income: -183954.40
CELL.V cash_flow (annual, 2023-06-30) — Operating Cash Flow: -514673.00
CELL.V cash_flow (annual, 2023-06-30) — Operating Gains Losses: -84353.00
CELL.V income_statement (annual, 2023-06-30) — Operating Income: -1084271.00
CELL.V income_statement (annual, 2023-06-30) — Operating Revenue: 0.00
CELL.V balance_sheet (annual, 2023-06-30) — Ordinary Shares Number: 170423653.00
CELL.V income_statement (annual, 2023-06-30) — Other Gand A: 479813.00
CELL.V income_statement (annual, 2023-06-30) — Other Income Expense: 2254674.00
CELL.V cash_flow (annual, 2023-06-30) — Other Non Cash Items: 1558.00
CELL.V balance_sheet (annual, 2023-06-30) — Other Non Current Assets: 35000.00
CELL.V income_statement (annual, 2023-06-30) — Other Operating Expenses: 1558.00
CELL.V balance_sheet (annual, 2023-06-30) — Other Properties: 482994.00
CELL.V balance_sheet (annual, 2023-06-30) — Other Short Term Investments: 3000000.00
CELL.V balance_sheet (annual, 2023-06-30) — Payables: 2659.00
CELL.V balance_sheet (annual, 2023-06-30) — Payables And Accrued Expenses: 29659.00
CELL.V balance_sheet (annual, 2023-06-30) — Prepaid Assets: 51938.00
CELL.V income_statement (annual, 2023-06-30) — Pretax Income: 1168850.00
CELL.V cash_flow (annual, 2023-06-30) — Proceeds From Stock Option Exercised: 0.00
CELL.V balance_sheet (annual, 2023-06-30) — Receivables: 8588.00
CELL.V income_statement (annual, 2023-06-30) — Reconciled Cost Of Revenue: 7090.00
CELL.V income_statement (annual, 2023-06-30) — Reconciled Depreciation: 7090.00
CELL.V income_statement (annual, 2023-06-30) — Rent And Landing Fees: 25402.00
CELL.V income_statement (annual, 2023-06-30) — Rent Expense Supplemental: 25402.00
CELL.V cash_flow (annual, 2023-06-30) — Repayment Of Debt: -8000.00
CELL.V balance_sheet (annual, 2023-06-30) — Retained Earnings: -10839260.00
CELL.V income_statement (annual, 2023-06-30) — Salaries And Wages: 531643.00
CELL.V cash_flow (annual, 2023-06-30) — Sale Of Investment: 0.00
CELL.V income_statement (annual, 2023-06-30) — Securities Amortization: 1558.00
CELL.V income_statement (annual, 2023-06-30) — Selling And Marketing Expense: 18750.00
CELL.V income_statement (annual, 2023-06-30) — Selling General And Administration: 1075623.00
CELL.V balance_sheet (annual, 2023-06-30) — Share Issued: 170423653.00
CELL.V income_statement (annual, 2023-06-30) — Special Income Charges: -290397.00
CELL.V cash_flow (annual, 2023-06-30) — Stock Based Compensation: 531643.00
CELL.V balance_sheet (annual, 2023-06-30) — Stockholders Equity: 7769543.00
CELL.V balance_sheet (annual, 2023-06-30) — Tangible Book Value: 7769543.00
CELL.V income_statement (annual, 2023-06-30) — Tax Effect Of Unusual Items: 901869.60
CELL.V income_statement (annual, 2023-06-30) — Tax Rate For Calcs: 0.40
CELL.V balance_sheet (annual, 2023-06-30) — Taxes Receivable: 8588.00
CELL.V balance_sheet (annual, 2023-06-30) — Total Assets: 7824667.00
CELL.V balance_sheet (annual, 2023-06-30) — Total Capitalization: 7769543.00
CELL.V balance_sheet (annual, 2023-06-30) — Total Debt: 25465.00
CELL.V balance_sheet (annual, 2023-06-30) — Total Equity Gross Minority Interest: 7769543.00
CELL.V income_statement (annual, 2023-06-30) — Total Expenses: 1084271.00
CELL.V balance_sheet (annual, 2023-06-30) — Total Liabilities Net Minority Interest: 55124.00
CELL.V balance_sheet (annual, 2023-06-30) — Total Non Current Assets: 517994.00
CELL.V balance_sheet (annual, 2023-06-30) — Total Non Current Liabilities Net Minority Interest: 15129.00
CELL.V income_statement (annual, 2023-06-30) — Total Other Finance Cost: 1553.00
CELL.V income_statement (annual, 2023-06-30) — Total Unusual Items: 2254674.00
CELL.V income_statement (annual, 2023-06-30) — Total Unusual Items Excluding Goodwill: 2254674.00
CELL.V cash_flow (annual, 2023-06-30) — Unrealized Gain Loss On Investment Securities: -2530000.00
CELL.V balance_sheet (annual, 2023-06-30) — Working Capital: 7266678.00
CELL.V income_statement (annual, 2024-06-30) — +Operating Expense: 3439715.00
CELL.V income_statement (annual, 2024-06-30) — +Total Revenue: 0.00
CELL.V balance_sheet (annual, 2024-06-30) — Accounts Payable: 101074.00
CELL.V cash_flow (annual, 2024-06-30) — Asset Impairment Charge: 0.00
CELL.V income_statement (annual, 2024-06-30) — Basic Average Shares: 185895159.00
CELL.V income_statement (annual, 2024-06-30) — Basic EPS: -0.01
CELL.V cash_flow (annual, 2024-06-30) — Beginning Cash Position: 4246147.00
CELL.V balance_sheet (annual, 2024-06-30) — Capital Lease Obligations: 15129.00
CELL.V balance_sheet (annual, 2024-06-30) — Capital Stock: 15259304.00
CELL.V balance_sheet (annual, 2024-06-30) — Cash And Cash Equivalents: 6067899.00
CELL.V balance_sheet (annual, 2024-06-30) — Cash Cash Equivalents And Short Term Investments: 6067899.00
CELL.V balance_sheet (annual, 2024-06-30) — Cash Financial: 6067899.00
CELL.V cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Financing Activities: 753000.00
CELL.V cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Investing Activities: 4398245.00
CELL.V cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Operating Activities: -3329493.00
CELL.V cash_flow (annual, 2024-06-30) — Change In Payable: 112953.00
CELL.V cash_flow (annual, 2024-06-30) — Change In Payables And Accrued Expense: 112953.00
CELL.V cash_flow (annual, 2024-06-30) — Change In Prepaid Assets: -25522.00
CELL.V cash_flow (annual, 2024-06-30) — Change In Receivables: -36657.00
CELL.V cash_flow (annual, 2024-06-30) — Change In Working Capital: 50774.00
CELL.V cash_flow (annual, 2024-06-30) — Changes In Cash: 1821752.00
CELL.V balance_sheet (annual, 2024-06-30) — Common Stock: 15259304.00
CELL.V balance_sheet (annual, 2024-06-30) — Common Stock Equity: 8180105.00